The genes (i.e., metallothionein gene family, C19orf33, ELF3, GRB7, IL18, NRN1, and RBM47) in the identified differentially regulated gene networks can be considered as key markers to understand the mechanisms involving drug resistance of azacitidine and AML. This evidence concerns the gene ELF3 and acute myeloid leukemia.